Analyzing the use and impact of elexacaftor/tezacaftor/ivacaftor on total cost of care and other health care resource utilization in a commercially insured population.

ABSTRACT:

SUBMITTER: Smith S 

PROVIDER: S-EPMC10372948 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature